Perspectives on the Risk-Stratified Treatment of Multiple Myeloma

被引：29

作者：

Davies, Faith E. ^{[1
]}

Pawlyn, Charlotte ^{[2
,3
]}

Usmani, Saad Z. ^{[4
]}

San-Miguel, Jesus F. ^{[5
]}

Einsele, Hermann ^{[6
]}

Boyle, Eileen M. ^{[1
]}

Corre, Jill ^{[7
,8
]}

Auclair, Daniel ^{[9
]}

Cho, Hearn Jay ^{[9
,10
]}

Lonial, Sagar ^{[11
]}

Sonneveld, Pieter ^{[12
]}

Stewart, A. Keith ^{[13
,14
]}

Bergsagel, P. Leif ^{[15
]}

Kaiser, Martin F. ^{[3
,16
]}

Weisel, Katja ^{[17
]}

Keats, Jonathan J. ^{[18
]}

Mikhael, Joseph R. ^{[19
]}

Morgan, Kathryn E. ^{[20
]}

Ghobrial, Irene M. ^{[21
]}

Orlowski, Robert Z. ^{[22
]}

Landgren, C. Ola ^{[23
]}

Gay, Francesca ^{[24
]}

Caers, Joseph ^{[25
]}

Chng, Wee Joo ^{[26
,27
,28
,29
]}

Chari, Ajai ^{[10
]}

Walker, Brian A. ^{[30
]}

Kumar, Shaji K. ^{[31
]}

Costa, Luciano J. ^{[32
]}

Anderson, Kenneth C. ^{[21
]}

Morgan, Gareth J. ^{[1
]}

机构：

[1] NYU Langone, Perlmutter Canc Ctr, New York, NY USA

[2] Inst Canc Res, Div Canc Therapeut, London, England

[3] Royal Marsden Hosp, Dept Haematol, London, England

[4] Mem Sloan Kettering Canc Ctr, Dept Med, Myeloma Serv, 1275 York Ave, New York, NY 10021 USA

[5] Clin Univ Navarra, CIBERONC, IDISNA, CIMA, Pamplona, Spain

[6] Univ Hosp Wurzburg, Dept Internal Med 2, Wurzburg, Germany

[7] Inst Univ Canc, Unite Genom Myelome, Toulouse, France

[8] Inst Natl Sante & Rech Med, Paris, France

[9] Multiple Myeloma Res Fdn, Norwalk, CT USA

[10] Icahn Sch Med Mt Sinai, Multiple Myeloma Ctr Excellence, New York, NY 10029 USA

[11] Emory Univ, Winship Canc Inst, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA

[12] Erasmus MC Canc Inst, Dept Hematol, Rotterdam, Netherlands

[13] Univ Hlth Network, Toronto, ON, Canada

[14] Princess Margaret Canc Ctr, Toronto, ON, Canada

[15] Mayo Clin, Dept Med, Phoenix, AZ USA

[16] Inst Canc Res, Div Genet & Epidemiol, London, England

[17] Univ Med Ctr Hamburg Eppendorf, Dept Oncol Hematol & Bone Marrow Transplantat, Sect Pneumol, Hamburg, Germany

[18] Translat Genom Res Inst, Integrated Canc Genom, Phoenix, AZ USA

[19] City Hope Canc Ctr, Translat Genom Res Inst, Phoenix, AZ USA

[20] Myeloma Patients Europe, Brussels, Belgium

[21] Harvard Med Sch, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA

[22] Univ Texas MD Anderson Canc Ctr, Dept Lymphoma Myeloma, Houston, TX 77030 USA

[23] Univ Miami, Sylvester Comprehens Canc Ctr, Myeloma Program, Miami, FL USA

[24] Univ Torino, Div Hematol, Turin, Italy

[25] Ctr Hosp Univ CHU Liege, Dept Hematol, Liege, Belgium

[26] Natl Univ Canc Inst, Singapore, Singapore

[27] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore, Singapore

[28] Natl Univ Singapore, NUS Ctr Canc Res, Yong Loo Lin Sch Med, Singapore, Singapore

[29] Natl Univ Singapore, Dept Med, Yong Loo Lin Sch Med, Singapore, Singapore

[30] Indiana Univ, Melvin & Bren Simon Comprehens Canc Ctr, Div Hematol Oncol, Indianapolis, IN USA

[31] Mayo Clin, Dept Hematol, Rochester, MN USA

[32] Univ Alabama Birmingham, Dept Med, Div Hematol & Oncol, Birmingham, AL 35294 USA

来源：

BLOOD CANCER DISCOVERY | 2022年 / 3卷 / 07期

关键词：

STEM-CELL TRANSPLANTATION; INTERNATIONAL STAGING SYSTEM; MINIMAL RESIDUAL DISEASE; TERM-FOLLOW-UP; LENALIDOMIDE MAINTENANCE; PLUS BORTEZOMIB; GENE-EXPRESSION; DOUBLE-BLIND; DEXAMETHASONE; THERAPY;

D O I：

10.1158/2643-3230.BCD-21-0205

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The multiple myeloma treatment landscape has changed dramatically. This change, paralleled by an increase in scientific knowledge, has resulted in significant improvement in survival. However, heterogeneity remains in clinical outcomes, with a proportion of patients not benefiting from current approaches and continu-ing to have a poor prognosis. A significant proportion of the variability in outcome can be predicted on the basis of clinical and biochemical parameters and tumor-acquired genetic variants, allowing for risk stratification and a more personalized approach to therapy. This article discusses the principles that can enable the rational and effective development of therapeutic approaches for high-risk multiple myeloma.

引用

页码：273 / 284

页数：12

共 108 条

[11] Improving prognostic assignment in older adults with multiple myeloma using acquired genetic features, clonal hemopoiesis and telomere length
Boyle, Eileen M.
Williams, Louis
Blaney, Patrick
Ashby, Cody
Bauer, Michael
Walker, Brian A.
Ghamlouch, Hussein
Choi, Jinyoung
Perrial, Emeline
Wang, Yubao
Caro, Jessica
Stoeckle, James H.
Arbini, Arnaldo
Kaminetzky, David
Braunstein, Marc
Bruno, Benedetto
Razzo, Beatrice
Diamond, Benjamin
Maclachlan, Kylee
Maura, Francesco
Landgren, Ola
Litke, Rachel
Fegan, Christopher D.
Keats, Johnathan
Auclair, Daniel
Davies, Faith E.
Morgan, Gareth J.
[J]. LEUKEMIA, 2022, 36 (01) : 221 - 224
[12] BRAF and DIS3 Mutations Associate with Adverse Outcome in a Long-term Follow-up of Patients with Multiple Myeloma
Boyle, Eileen M.
Ashby, Cody
Tytarenko, Ruslana G.
Deshpande, Shayu
Wang, Hongwei
Wang, Yan
Rosenthal, Adam
Sawyer, Jeffrey
Tian, Erming
Flynt, Erin
Hoering, Antje
Johnson, Sarah K.
Rutherford, Michael W.
Wardell, Christopher P.
Bauer, Michael A.
Dumontet, Charles
Facon, Thierry
Thanendrarajan, Sharmilan
Schinke, Carolina D.
Zangari, Maurizio
van Rhee, Frits
Barlogie, Bart
Cairns, David
Jackson, Graham
Thakurta, Anjan
Davies, Faith E.
Morgan, Gareth J.
Walker, Brian A.
[J]. CLINICAL CANCER RESEARCH, 2020, 26 (10) : 2422 - 2432
[13] MUKnine OPTIMUM protocol: a screening study to identify high-risk patients with multiple myeloma suitable for novel treatment approaches combined with a phase II study evaluating optimised combination of biological therapy in newly diagnosed high-risk multiple myeloma and plasma cell leukaemia
Brown, Sarah
Sherratt, Debbie
Hinsley, Samantha
Flanagan, Louise
Roberts, Sadie
Walker, Katrina
Hall, Andrew
Pratt, Guy
Messiou, Christina
Jenner, Matthew
Kaiser, Martin
[J]. BMJ OPEN, 2021, 11 (03):
[14] Early relapse after high-dose melphalan autologous stem cell transplant predicts inferior survival and is associated with high disease burden and genetically high-risk disease in multiple myeloma
Bygrave, Ceri
Pawlyn, Charlotte
Davies, Faith
Craig, Zoe
Cairns, David
Hockaday, Anna
Jenner, Matthew
Cook, Gordon
Drayson, Mark
Owen, Roger
Gregory, Walter
Morgan, Gareth
Jackson, Graham
Kaiser, Martin
[J]. BRITISH JOURNAL OF HAEMATOLOGY, 2021, 193 (03) : 551 - 555
[15] Autologous haematopoietic stem-cell transplantation versus bortezomib-melphalan-prednisone, with or without bortezomib-lenalidomide-dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02/HO95): a multicentre, randomised, open-label, phase 3 study
Cavo, Michele
Gay, Francesca
Beksac, Meral
Pantani, Lucia
Petrucci, Maria Teresa
Dimopoulos, Meletios A.
Dozza, Luca
van der Holt, Bronno
Zweegman, Sonja
Oliva, Stefania
van der Velden, Vincent H. J.
Zamagni, Elena
Palumbo, Giuseppe A.
Patriarca, Francesca
Montefusco, Vittorio
Galli, Monica
Maisnar, Vladimir
Gamberi, Barbara
Hansson, Markus
Belotti, Angelo
Pour, Ludek
Ypma, Paula
Grasso, Mariella
Croockewit, Alexsandra
Ballanti, Stelvio
Offidani, Massimo
Vincelli, Iolanda D.
Zambello, Renato
Liberati, Anna Marina
Andersen, Niels Frost
Broijl, Annemiek
Troia, Rossella
Pascarella, Anna
Benevolo, Giulia
Levin, Mark-David
Bos, Gerard
Ludwig, Heinz
Aquino, Sara
Morelli, Anna Maria
Wu, Ka Lung
Boersma, Rinske
Hajek, Roman
Durian, Marc
Borne, Peter A. von dem
di Toritto, Tommaso Caravita
Zander, Thilo
Specchia, Giorgina
Waage, Anders
Gimsing, Peter
Mellqvist, Ulf-Henrik
[J]. LANCET HAEMATOLOGY, 2020, 7 (06): : E456 - E468
[16] Role of 18F-FDG PET/CT in the diagnosis and management of multiple myeloma and other plasma cell disorders: a consensus statement by the International Myeloma Working Group
Cavo, Michele
Terpos, Evangelos
Nanni, Cristina
Moreau, Philippe
Lentzsch, Suzanne
Zweegman, Sonja
Hillengass, Jens
Engelhardt, Monika
Usmani, Saad Z.
Vesole, David H.
San-Miguel, Jesus
Kumar, Shaji K.
Richardson, Paul G.
Mikhael, Joseph R.
da Costa, Fernando Leal
Dimopoulos, Meletios-Athanassios
Zingaretti, Chiara
Abildgaard, Niels
Goldschmidt, Hartmut
Orlowski, Robert Z.
Chng, Wee Joo
Einsele, Hermann
Lonial, Sagar
Barlogie, Bart
Anderson, Kenneth C.
Rajkumar, S. Vincent
Durie, Brian G. M.
Zamagni, Elena
[J]. LANCET ONCOLOGY, 2017, 18 (04) : E206 - E217
[17] Defining the vulnerable patient with myeloma-a frailty position paper of the European Myeloma Network
Cook, Gordon
Larocca, Alessandra
Facon, Thierry
Zweegman, Sonja
Engelhardt, Monika
[J]. LEUKEMIA, 2020, 34 (09) : 2285 - 2294
[18] del(17p) without TP53 mutation confers a poor prognosis in intensively treated newly diagnosed patients with multiple myeloma
Corre, Jill
Perrot, Aurore
Caillot, Denis
Belhadj, Karim
Hulin, Cyrille
Leleu, Xavier
Mohty, Mohamad
Facon, Thierry
Buisson, Laure
Do Souto, Laura
Lannes, Romain
Dufrechou, Stephanie
Prade, Nais
Orsini-Piocelle, Frederique
Voillat, Laurent
Jaccard, Arnaud
Karlin, Lionel
Macro, Margaret
Brechignac, Sabine
Dib, Mamoun
Sanhes, Laurence
Fontan, Jean
Clement-Filliatre, Lauriane
Marolleau, Jean-Pierre
Minvielle, Stephane
Moreau, Philippe
Avet-Loiseau, Herve
[J]. BLOOD, 2021, 137 (09) : 1192 - 1195
[19] Early relapse after autologous transplant for myeloma is associated with poor survival regardless of cytogenetic risk
Corre, Jill
Montes, Lydia
Martin, Elodie
Perrot, Aurore
Caillot, Denis
Leleu, Xavier
Belhadj, Karim
Facon, Thierry
Hulin, Cyrille
Mohty, Mohamad
Fontan, Jean
Macro, Margaret
Brechignac, Sabine
Jaccard, Arnaud
Stoppa, Anne-Marie
Orsini-Piocelle, Frederique
Adiko, Didier
Voillat, Laurent
Keddar, Faiza
Barry, Marly
Demarquette, Helene
Certain, Marie-Noelle
Plantier, Isabelle
Roussel, Murielle
Hebraud, Benjamin
Filleron, Thomas
Attal, Michel
Avet-Loiseau, Herve
[J]. HAEMATOLOGICA, 2020, 105 (09) : E480 - E483
[20] Daratumumab, Carfilzomib, Lenalidomide, and Dexamethasone With Minimal Residual Disease Response-Adapted Therapy in Newly Diagnosed Multiple Myeloma
Costa, Luciano J.
Chhabra, Saurabh
Medvedova, Eva
Dholaria, Bhagirathbhai R.
Schmidt, Timothy M.
Godby, Kelly N.
Silbermann, Rebecca
Dhaka, Binod
Bal, Susan
Gid, Smith
D'Souza, Anita
Hall, Aric
Hardwick, Pamela
Omel, James
Cornell, Robert F.
Had, Parameswaran
Callander, Natalie S.
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (25) : 2901 - +

← 1 2 3 4 5 6 7 8 9 10 →